Deakin University
Browse

File(s) under permanent embargo

Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease

Version 2 2024-06-19, 19:50
Version 1 2023-07-12, 00:13
journal contribution
posted on 2024-06-19, 19:50 authored by Victoria ER Parker, Thuong HoangThuong Hoang, Heike Schlichthaar, Fraser W Gibb, Barbara Wenzel, Maximillian G Posch, Ludger Rose, Yi-Ting Chang, Marcella Petrone, Lars Hansen, Philip Ambery, Lutz Jermutus, Hiddo JL Heerspink, Rory J McCrimmon
Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease

History

Journal

DIABETES OBESITY & METABOLISM

Volume

24

Pagination

1360-1369

Location

London, Eng.

Publisher DOI

ISSN

1462-8902

eISSN

1463-1326

Language

English

Author URL

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

7

Publisher

Wiley

Usage metrics

    Research Publications

    Categories

    Keywords

    CARDIOVASCULAR OUTCOMESEndocrinology & MetabolismGLP-1Life Sciences & BiomedicineLIRAGLUTIDEMECHANISTIC INSIGHTSRENAL OUTCOMESScience & Technology

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC